Cargando…
Spheroacanthocytes secondary to novel tyrosine kinase inhibitors
Autores principales: | Ashby, Michael, Low, Michael Sze Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175828/ https://www.ncbi.nlm.nih.gov/pubmed/35845003 http://dx.doi.org/10.1002/jha2.104 |
Ejemplares similares
-
Cutaneous cryptococcosis in a patient with myelofibrosis receiving JAK‐inhibitor
por: Chen, Jui‐Che, et al.
Publicado: (2021) -
A novel SF3B1 variant in a patient with MDS with ring sideroblasts
por: Al‐Ghamdi, Yahya A., et al.
Publicado: (2022) -
Multifocal splenic lesions in primary AL amyloidosis secondary to amyloidosis with giant cell granulomatous reaction
por: Bhushan, Mishi, et al.
Publicado: (2020) -
Secondary effects after belantamab treatment: A new anti‐B‐cell maturation antigen monoclonal antibody for multiple myeloma
por: Garrido Paniagua, Sara, et al.
Publicado: (2021) -
Marrow tuberculosis without granuloma formation in a patient with human immunodeficiency virus infection
por: Lam, Wing Kit, et al.
Publicado: (2023)